000			01903 a2200493 4500
005			20250516050859.0
264		0	_c20111012
008			201110s 0 0 eng d
022			_a1879-0631
024	7		_a10.1016/j.lfs.2011.07.004 _2doi
040			_aNLM _beng _cNLM
100	1		_aGonçalves, António Pedro
245	0	0	_aOrthovanadate-induced cell death in RET/PTC1-harboring cancer cells involves the activation of caspases and altered signaling through PI3K/Akt/mTOR. _h[electronic resource]
260			_bLife sciences _cSep 2011
300			_a371-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAntineoplastic Agents _xpharmacology
650	0	4	_aApoptosis
650	0	4	_aCarcinoma
650	0	4	_aCarcinoma, Papillary
650	0	4	_aCaspases _xmetabolism
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aEnzyme Activation
650	0	4	_aGlial Cell Line-Derived Neurotrophic Factor _xmetabolism
650	0	4	_aHumans
650	0	4	_aMembrane Potential, Mitochondrial _xdrug effects
650	0	4	_aOncogene Protein v-akt _xmetabolism
650	0	4	_aOncogene Proteins, Fusion _xmetabolism
650	0	4	_aPhosphatidylinositol 3-Kinases _xmetabolism
650	0	4	_aPhosphorylation
650	0	4	_aProtein-Tyrosine Kinases _xantagonists & inhibitors
650	0	4	_aReactive Oxygen Species _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aTOR Serine-Threonine Kinases _xmetabolism
650	0	4	_aThyroid Cancer, Papillary
650	0	4	_aThyroid Neoplasms _xgenetics
650	0	4	_aTumor Cells, Cultured
650	0	4	_aVanadates _xpharmacology
700	1		_aVideira, Arnaldo
700	1		_aSoares, Paula
700	1		_aMáximo, Valdemar
773	0		_tLife sciences _gvol. 89 _gno. 11-12 _gp. 371-7
856	4	0	_uhttps://doi.org/10.1016/j.lfs.2011.07.004 _zAvailable from publisher's website
999			_c21052647 _d21052647